BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8531651)

  • 21. Treatment of human acute schistosomiasis with oxamniquine induces an increase in interferon-gamma response to Schistosoma mansoni antigens.
    de Souza JR; Morais CN; Aroucha ML; Miranda PJ; Barbosa CS; Domingues AL; Carvalho Júnior LB; Abath FG; Montenegro SM
    Mem Inst Oswaldo Cruz; 2007 May; 102(2):225-8. PubMed ID: 17426890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of steroids and schistosomicides in the treatment of experimental schistosomiasis.
    Lambertucci JR; Modha J; Curtis R; Doenhoff M
    Trans R Soc Trop Med Hyg; 1989; 83(3):354-7. PubMed ID: 2515622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immune-dependence of chemotherapy in experimental schistosomiasis.
    Doenhoff MJ
    Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():31-7. PubMed ID: 2517867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase].
    Campos R; Pinto PL; Amato Neto V; Moreira AA
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
    Fallon PG; Fookes RE; Wharton GA
    Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of schistosomiasis mansoni].
    de Carvalho SA
    Rev Paul Med; 1982; 99(2):26-8. PubMed ID: 7156674
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of alternating therapy with oxamniquine and praziquantel to treat Schistosoma mansoni in children following failure of first treatment.
    Katz N; Rocha RS; de Souza CP; Coura Filho P; Bruce JI; Coles GC; Kinoti GK
    Am J Trop Med Hyg; 1991 May; 44(5):509-12. PubMed ID: 1905880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Praziquantel versus praziquantel associated with immunomodulators in mice infected with schistosoma mansoni: A systematic review and meta-analysis.
    Silva JCS; Bernardes MVAS; Melo FL; Sá MPBO; Carvalho BM
    Acta Trop; 2020 Apr; 204():105359. PubMed ID: 31987779
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of praziquantel and oxamniquine on a Saudi Arabian strain of Schistosoma mansoni in mice.
    Ghandour AM; Banaja AA; Shalaby IM
    J Helminthol; 1990 Mar; 64(1):62-4. PubMed ID: 2110944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new approach to the treatment of acute schistosomiasis.
    Lambertucci JR
    Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():23-30. PubMed ID: 2517865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schistosoma mansoni: chemotherapy of infections of different ages.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current results in the clinical therapy of schistosomiasis mansoni.
    Katz N
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):8-17, 123-33. PubMed ID: 7006041
    [No Abstract]   [Full Text] [Related]  

  • 34. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
    Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
    Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schistogram changes after administration of antischistosomal drugs in mice at the early phase of Schistosoma mansoni infection.
    Vimieiro AC; Araújo N; Katz N; Kusel JR; Coelho PM
    Mem Inst Oswaldo Cruz; 2013 Nov; 108(7):881-6. PubMed ID: 24271044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined praziquantel-oxamniquine treatment of schistosomiasis.
    Farid Z; el Masry NA; Bassily S; Kamal M; Kilpatrick ME
    Trans R Soc Trop Med Hyg; 1990; 84(6):807. PubMed ID: 2128982
    [No Abstract]   [Full Text] [Related]  

  • 37. [Schistosomiasis mansoni simulating bladder neoplasia].
    Lopes EJ; dos Santos TC; Martins V
    Rev Soc Bras Med Trop; 2006; 39(3):287-8. PubMed ID: 16906256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Low effectiveness of an oxamniquine and praziquantel combination in the therapy of schistosomiasis mansoni].
    Dietze R; Prata A
    Rev Soc Bras Med Trop; 1986; 19(4):247-9. PubMed ID: 3150592
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug resistance or tolerance in schistosomes?
    Coles GC
    Trends Parasitol; 2002 Jul; 18(7):294. PubMed ID: 12379947
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the reversal of schistosomiasis hepatic fibrosis after specific therapy. Histopathologic study].
    Chapadeiro E; Pitanga LC
    Rev Soc Bras Med Trop; 1997; 30(1):53-6. PubMed ID: 9026832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.